Related Experiment Video
Updated: May 1, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
7.5K
Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives
1Department of Intracellular Signalling and Transport, Institute of Cytology, Russian Academy of Sciences and Research, Saint-Petersburg, Russia. grants@almazovcentre.ru
Reviews in the Neurosciences
|April 20, 2010
Summary
Parkinson's disease cell therapy shows promise using stem cells like human embryonic stem cells (hESCs). However, ethical, safety, and technical challenges must be overcome for successful transplantation.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Parkinson's disease (PD) involves the degeneration of dopaminergic neurons in the substantia nigra pars compacta.
- Cell replacement therapy is a promising strategy for PD due to the specific depletion of a single cell type.
- Identifying suitable donor cell sources is critical for effective cell transplantation.
Purpose of the Study:
- To review the potential of various stem cell sources for Parkinson's disease treatment.
- To discuss the challenges and considerations for stem cell-based therapies in PD.
- To provide an updated outlook on stem cell applications in Parkinson's disease.
Main Methods:
- Review of existing literature on stem cell sources for PD.
- Analysis of differentiation protocols for generating dopaminergic neurons.
- Examination of transplantation techniques and safety concerns associated with stem cells.
Main Results:
- Human embryonic stem cells (hESCs), neural stem cells (hNSCs), and mesenchymal stem cells (hMSCs) are potential sources for dopaminergic neuron replacement.
- Various differentiation protocols exist for generating these neuronal subtypes.
- Significant ethical, safety (xenotransplantation, tumorigenicity), and technical hurdles impede clinical application.
Conclusions:
- Stem cell-based therapies offer potential for Parkinson's disease treatment through dopaminergic neuron replacement.
- Overcoming ethical, safety, and technical challenges is essential for the clinical translation of these therapies.
- Further research is needed to optimize stem cell differentiation, transplantation, and ensure long-term safety.
More Related Videos
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
6.6K
07:32Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
Published on: December 28, 2021
3.6K
Related Concept Videos
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28